Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | -0.94% | 240.32 | 1.3% | $790.96m | |
| IMMU | Immunomedics, Inc. | 0.15% | 85.30 | 11.0% | $689.14m | |
| MRNA | Moderna, Inc. | -2.96% | 65.17 | 0.0% | $688.38m | |
| GILD | Gilead Sciences, Inc. | -1.33% | 62.25 | 1.0% | $574.97m | |
| NVAX | Novavax, Inc. | 0.86% | 102.44 | 96.5% | $560.41m | |
| ILMN | Illumina, Inc. | 4.88% | 286.31 | 3.5% | $502.92m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.37% | 557.46 | 2.7% | $425.08m | |
| BIIB | Biogen, Inc. | -0.79% | 270.04 | 1.6% | $333.15m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.26% | 263.13 | 1.9% | $328.25m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.37% | 112.02 | 2.0% | $278.23m | |
| SRNE | Sorrento Therapeutics, Inc. | -4.27% | 9.19 | 1.5% | $246.35m | |
| EXAS | EXACT Sciences Corp. | 26.85% | 94.31 | 20.7% | $232.04m | |
| SGEN | Seattle Genetics, Inc. | 0.09% | 179.43 | 6.0% | $203.87m | |
| VXRT | Vaxart, Inc. | -4.17% | 6.89 | 0.0% | $198.58m | |
| MNTA | Momenta Pharmaceuticals, Inc. | 0.19% | 52.39 | 3.0% | $197.85m |
Company Profile
Cortexyme, Inc. is a biopharmaceutical company, which develops therapeutics based on data supporting a new theory of the cause of Alzheimer's and other neurodegenerative disorders. Its product, COR388, is in clinical trial. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.